BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19887741)

  • 21. Resistance to the anti-proliferative activity of recombinant arginine deiminase in cell culture correlates with the endogenous enzyme, argininosuccinate synthetase.
    Shen LJ; Lin WC; Beloussow K; Shen WC
    Cancer Lett; 2003 Mar; 191(2):165-70. PubMed ID: 12618329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the arginine deiminase of Streptococcus equi subsp. zooepidemicus.
    Hong K
    Can J Microbiol; 2006 Sep; 52(9):868-76. PubMed ID: 17110979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant arginine deiminase reduces inducible nitric oxide synthase iNOS-mediated neurotoxicity in a coculture of neurons and microglia.
    Yu HH; Wu FL; Lin SE; Shen LJ
    J Neurosci Res; 2008 Oct; 86(13):2963-72. PubMed ID: 18627024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating Five Escherichia coli Derivative Strains as a Platform for Arginine Deiminase Overproduction.
    Abdollahi S; Morowvat MH; Savardashtaki A; Irajie C; Najafipour S; Ghasemi Y
    Recent Pat Biotechnol; 2022; 16(2):174-183. PubMed ID: 34809551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reconstitution of an active arginine deiminase pathway in Mycoplasma pneumoniae M129.
    Rechnitzer H; Rottem S; Herrmann R
    Infect Immun; 2013 Oct; 81(10):3742-9. PubMed ID: 23897620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant Arginine Deiminase from
    Mendoza RM; Song JH; Jung YT; Paik HD; Park YS; Kang DK
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of mouse uterine peptidylarginine deiminase in Escherichia coli: construction of expression plasmid and properties of the recombinant enzyme.
    Ohsugi I; Takahara H; Shiraiwa M; Sugawara K
    Arch Biochem Biophys; 1995 Feb; 317(1):62-8. PubMed ID: 7872804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of arginosuccinate synthetase (ASS) expression affects the antiproliferative activity of arginine deiminase (ADI) in melanoma cells.
    Manca A; Sini MC; Izzo F; Ascierto PA; Tatangelo F; Botti G; Gentilcore G; Capone M; Mozzillo N; Rozzo C; Cossu A; Tanda F; Palmieri G
    Oncol Rep; 2011 Jun; 25(6):1495-502. PubMed ID: 21424129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracellular delivery of recombinant arginine deiminase (rADI) by heparin-binding hemagglutinin adhesion peptide restores sensitivity in rADI-resistant cancer cells.
    Wu FL; Yeh TH; Chen YL; Chiu YC; Cheng JC; Wei MF; Shen LJ
    Mol Pharm; 2014 Aug; 11(8):2777-86. PubMed ID: 24950134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo anti-tumor activity of arginine deiminase purified from Mycoplasma arginini.
    Takaku H; Takase M; Abe S; Hayashi H; Miyazaki K
    Int J Cancer; 1992 May; 51(2):244-9. PubMed ID: 1568792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arginine deiminase, a potential anti-tumor drug.
    Ni Y; Schwaneberg U; Sun ZH
    Cancer Lett; 2008 Mar; 261(1):1-11. PubMed ID: 18179862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arginine Deiminase Enzyme Evolving as a Potential Antitumor Agent.
    Somani RR; Chaskar PK
    Mini Rev Med Chem; 2018; 18(4):363-368. PubMed ID: 27538511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyto-adherence studies of the adhesin P50 of Mycoplasma hominis.
    Kitzerow A; Hadding U; Henrich B
    J Med Microbiol; 1999 May; 48(5):485-493. PubMed ID: 10229546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of Mycoplasma arginine deiminase in E. coli using stress-responsive proteins.
    Ahn KY; Lee B; Han KY; Song JA; Lee DS; Lee J
    Enzyme Microb Technol; 2014 Sep; 63():46-9. PubMed ID: 25039059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cloning and expression of the Mycoplasma hominis ftsZ for a cell division protein].
    Momynaliev KT; Smirnova OV; Lazarev VN; Akopian TA; Chelysheva VV; Govorun VM; Ayala JA; Simankova AN; Borkhsenius SN
    Genetika; 2003 Mar; 39(3):318-25. PubMed ID: 12722630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of arginine metabolic pathways as the potential anti-tumor mechanism of recombinant arginine deiminase.
    Shen LJ; Beloussow K; Shen WC
    Cancer Lett; 2006 Jan; 231(1):30-5. PubMed ID: 16356828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High sensitivity of human melanoma cell lines to the growth inhibitory activity of mycoplasmal arginine deiminase in vitro.
    Sugimura K; Ohno T; Kusuyama T; Azuma I
    Melanoma Res; 1992 Sep; 2(3):191-6. PubMed ID: 1450673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enzymatic production of l-citrulline by hydrolysis of the guanidinium group of l-arginine with recombinant arginine deiminase.
    Song W; Sun X; Chen X; Liu D; Liu L
    J Biotechnol; 2015 Aug; 208():37-43. PubMed ID: 26022421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arginine deiminase: recent advances in discovery, crystal structure, and protein engineering for improved properties as an anti-tumor drug.
    Han RZ; Xu GC; Dong JJ; Ni Y
    Appl Microbiol Biotechnol; 2016 Jun; 100(11):4747-60. PubMed ID: 27087524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibodies to Escherichia coli-expressed P46 and P65 membranous proteins for specific immunodetection of Mycoplasma hyopneumoniae in lungs of infected pigs.
    Cheikh Saad Bouh K; Shareck F; Dea S
    Clin Diagn Lab Immunol; 2003 May; 10(3):459-68. PubMed ID: 12738649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.